生物年龄和年龄加速预测阿尔茨海默病 血生物标志物水平
Jaclyn M Eissman1,2, Yiyi Ma1,2, Min Qiao1,2
1Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, 10032, USA.
medRxiv : the preprint server for health sciences
|July 15, 2025
概括
表观遗传时钟使用血液数据预测西班牙裔成年人患阿尔茨海默病 (AD) 的风险. 生物年龄加速与阿尔茨海默病诊断和关键生物标志物如P-Tau217.7相关.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 表观遗传钟显示出预测病态衰老和阿尔茨海默病 (AD) 风险的潜力.
- 之前的研究对血液和非欧洲人群的时钟疗效产生了不同的结果.
研究的目的:
- 在西班牙裔群体中使用血液甲基化数据构建和验证表观遗传钟.
- 评估生物年龄和年龄加速与阿尔茨海默病诊断和血生物标志物的关联.
主要方法:
- 从704名老年西班牙裔成人的血液甲基化数据开发了表观遗传钟.
- 分析了生物年龄,年龄加速,阿尔茨海默病诊断和血生物标志物 (包括P-Tau217) 之间的关联.
主要成果:
- 生物年龄和年龄加速与性别,阿尔茨海默病诊断和八种血生物标志物有显著联系.
- 在APOE-ε4非载体中,生物标志物关联性更强,与生物衰老相关的T细胞类型中的甲基化更强.
- 表观遗传钟分层了AD风险,并预测了血生物标志物水平,即使是在临床前阶段.
结论:
- 从血液中获得的表观遗传钟在拉丁裔队列中对阿尔茨海默病风险的分层有效.
- 生物衰老指标预测了关键的AD血生物标志物,提供了对临床前疾病阶段的见解.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.1K
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.5K
相关概念视频
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
Aging
188
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
188
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
